MASLD has replaced the old terminology NAFLD (non-alcoholic fatty liver disease) and is defined as the presence of 5 % hepato-steatosis without hepatocellular injury (i.e., without ballooning of hepatocyte, inflammation, or fibrosis) [6]
By supporting weight management and metabolic health, these therapies may positively impact risk factors associated with conditions like COVID-19 and heart disease
The international journal of biochemistry & cell biology , 37 (8), 1727-1737
[amazon box=B0773RCJ47/] Zu guter Letzt gibt es da noch den Melanocortin-Rezeptor-5 [MC5R] , der eine wesentliche Rolle bei der Regulierung der Krpertemperatur spielt
from an independent Chinese research group (PMID: 34827486) demonstrated that Dihexa rescued cognitive impairment in APP/PS1 Alzheimer's disease model mice via the PI3K/AKT signaling pathway, providing the first independent replication of cognitive enhancement effects